First Wave BioPharma Alpha and Beta Analysis
| FWBIDelisted Stock | USD 0.61 0.03 4.69% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as First Wave BioPharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in First Wave over a specified time horizon. Remember, high First Wave's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to First Wave's market risk premium analysis include:
Beta 0.55 | Alpha (1.88) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
First |
First Wave Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. First Wave market risk premium is the additional return an investor will receive from holding First Wave long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in First Wave. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate First Wave's performance over market.| α | -1.88 | β | 0.55 |
First Wave Fundamentals Vs Peers
Comparing First Wave's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze First Wave's direct or indirect competition across all of the common fundamentals between First Wave and the related equities. This way, we can detect undervalued stocks with similar characteristics as First Wave or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of First Wave's fundamental indicators could also be used in its relative valuation, which is a method of valuing First Wave by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare First Wave to competition |
| Fundamentals | First Wave | Peer Average |
| Return On Equity | -0.15 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Current Valuation | 72.56 M | 16.62 B |
| Shares Outstanding | 2.03 M | 571.82 M |
| Shares Owned By Insiders | 5.66 % | 10.09 % |
| Shares Owned By Institutions | 1.46 % | 39.21 % |
| Number Of Shares Shorted | 46.6 K | 4.71 M |
First Wave Opportunities
First Wave Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About First Wave Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including First or other delisted stocks. Alpha measures the amount that position in First Wave BioPharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
First Wave Upcoming Company Events
As portrayed in its financial statements, the presentation of First Wave's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, First Wave's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of First Wave's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of First Wave. Please utilize our Beneish M Score to check the likelihood of First Wave's management manipulating its earnings.
| 18th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 18th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with First Wave
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in First Stock
If you are still planning to invest in First Wave BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the First Wave's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |